The Epstein-Barr viral (EBV) genome of -170 kilobase pairs (kbp) is maintained as a plasmid in human B lymphoblasts transformed by the virus. We have identified a cis-acting element within 1.8 kbp of the viral genome that allows recombinant plasmids carrying it to be selected at high frequency and maintained as plasmids in cells latently infected by EBV. This functional element(s) requires a segment of DNA at least 800 bp and at most 1800 bp long, which contains a family of 30-bp tandem repeats at one end. Since this region confers efficient stable replication only to plasmids transfected into cells containing EBV genomes, its function probably requires trans-acting products encoded elsewhere in the viral genome.
virus that causes infectious mononucleosis and lymphoproliferative disorders in immunosuppressed individuals. It is also probably a causative agent of Burkitt lymphoma and nasopharyngeal carcinoma in some parts of the world (for a review, see ref. 1) . The causal association of EBV to diseases is likely a result of its capacity to induce unlimited proliferation in infected cells (2) . Progress in understanding cell transformation by EBV has been limited by its large genome [172 kilobase pairs (kbp)], the likelihood that more than one gene is required for transformation (3) , and the difficulty of introducing DNA stably into lymphocytes.
Our approach in studying transformation by EBV has been to seek to define the genomic location of functions required for viral DNA replication in transformed cells. Since the viral genome is maintained as an independently replicating plasmid (4) in most cells transformed in vivo or in vitro (4) (5) (6) (7) , plasmid replication functions are probably required for efficient transformation. In addition, mapping the location of viral replication functions would allow the construction of a small EBV plasmid replicon suitable for the manipulations of molecular cloning, which in turn could aid in locating the remaining genes involved in transformation. Using a method described below, we scanned the EBV genome for cis-acting functions that would permit stable plasmid replication, and we found one such element in the short unique region of the genome.
MATERIALS AND METHODS
Cell Lines. D98/Raji Cl 5 and D98/HR1 Cl 1 are hybrids between the human epithelial cell line D98 and the EBV genome-positive lymphoma lines Raji and P3JHR1, respectively (8, 9) . Both contain multiple copies of the EBV genome (ref. 10 ; unpublished results). These lines were grown in RPMI 1640 medium except during transfections, when they were in Dulbecco's modified Eagle's medium.
Human fibrosarcoma 143 cells (11) and mouse BALB 3T3 fibroblasts (12) were grown in Dulbecco's modified Eagle's medium. Both media were supplemented with 10% fetal bovine serum.
Transfections. About 1 x 106 cells in 6-cm dishes were transfected without carrier DNA, essentially as described by Graham and Van der Eb (13) , with plasmid DNAs at 10 ,g/ml in Hepes-buffered saline (14) . After 4 to 5 hr, cells were shocked with medium containing 20% (wt/vol) glycerol for 1-2 min (15) . The next day, cells were trypsinized and 4/5 and 1/5 of the cells were seeded into 9-cm dishes in medium containing 600 jig of G418 per ml. Concentrations of G418 given in this paper do not take into account the purity of G418 (46%) stated by the supplier (GIBCO).
RESULTS
Our approach in searching for origins of replication of EBV DNA was based on the possibility of such functions providing stability to transfected DNA in mammalian cells. It has been observed that when the herpes simplex virus (HSV) thymidine kinase (TK) gene is transfected into mammalian cells, 100 (16) to 1000 (17) times more cells express TK transiently than express it stably in their progeny. For the gene to be maintained stably it must be integrated, but most integration events apparently lead to the loss of enzyme expression (18) . If a recombinant plasmid carrying an EBV origin of replication were introduced into cells latently infected with EBV, then the recombinant plasmid might replicate along with the EBV plasmids in those cells. The possession of an EBV origin of replication by a recombinant plasmid might then increase its frequency of stable expression to a level approaching that observed soon after transfection.
To test this hypothesis, we first constructed the G418-selectable plasmid vector pKan2 (Fig. 1) , which uses the TK gene promoter for expression of drug resistance in mammalian cells (21) . Onto pKan2, we cloned fragments of EBV DNA that span the genome and overlap adjacent fragments except at two positions (0.023 and 0.533; Table 1 ). Using the calcium phosphate method (13), we then introduced these plasmids into cells that lacked or contained EBV genomes, and we determined the frequency at which each recombinant plasmid could give rise to G418-resistant colonies.
High Frequency of Stable Introduction of pBamC. Table 1 shows that pBamC (pKan2 containing the BamHI C fragment of EBV DNA) gave at least 10 to 100 times more G418-resistant colonies than other plasmids when tested in the EBV genome-positive cells D98/Raji. Similar results were obtained with D98/HR1 cells, which are also EBV genome positive. We have observed this high frequency of stable colony formation only with plasmids containing the BamHI C fragment or portions of it. One such plasmid, pBamCAJ, Abbreviations: EBV, Epstein-Barr virus; HSV-1, herpes simplex virus type 1; TK, thymidine kinase; bp, base pair(s).
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. In the experiments shown in Table 1 , -3500 of 1 x 106 D98/Raji cells transfected with pBamC (0.35%) grew into G418-resistant colonies. When we introduced the early region of simian virus 40 DNA into these cell lines using the same methods and monitored the synthesis of simian virus 40 T-antigen 24-48 hr later by an immunofluorescent assay, we observed antigen expression in 1%-3% of the D98/Raji cells or in 0.5%-1% of the D98/HR1 cells (data not shown). It therefore appears likely that if a D98/Raji or D98/HR1 cell acquires pBamC molecules in its nucleus so that the DNA is expressed, the cell has a high probability of maintaining that DNA.
pBamC Replicates as a Plasmid in EBV-Positive Cells. We analyzed DNA from G418-resistant D98/Raji cells that had been transfected with pBamC to check for the presence of free plasmid molecules. Pools of G418-resistant colonies or clones obtained from individual G418-resistant colonies were propagated under G418 selection, harvested, and their low molecular weight DNA was extracted by the method of Hirt (27) . When the low molecular weight DNA was electrophoresed in agarose gels and analyzed by the Southern technique (28) with pKan2 as a probe, the major hybridization (24) were inserted into pKan 2 using partial or complete digestion at BamHI, HindIII, Sal I, or Cla I cleavage sites. Plasmid names indicate the restriction fragments entirely contained on the plasmids, with fragment designations published for BamHI (25) , HindIII, and Sal 1 (26) . Inserts of three plasmids were reconstructed from simpler clones: pSal-Bam ends from phage EB 0-8 (26), pEcoD (25) , and pBamA; pBamW2YHFSalG from pBamW2Y and pHindB; pBamZRSalF from pBamZR and pSalF (26 tThe position of these repeats is arbitrarily assigned to be the first 4 of the 11 BamHI W fragments of the long internal repeat, which spans the map from 0.070 to 0.277. Because the long internal repeat begins within BamHI C, BamHI C and W overlap by 1200 bp. signals corresponded in mobility to the supercoiled and nicked forms of pBamC (Fig. 2) . In four clones of D98/Raji cells that arose after transfection with pBamC, plasmids were readily detected in supernatants of Hirt extracts, but no plasmid-derived sequences were detected in the residual high molecular weight DNA of the Hirt extracts as analyzed in overexposed autoradiograms (data not shown). (27) . The DNAs in the supernatants of the Hirt extracts were purified and analyzed undigested or after digestion with Bcl I. The DNAs (isolated from 1-4 x 106 cells) were electrophoresed in a 0.6% agarose gel, transferred to nitrocellulose (28) , and detected by hybridization to a 32P-labeled pKan2 probe and autoradiography (24) . The In contrast, low molecular weight DNA from G418-resistant BALB 3T3 cells transfected with pBamC did not contain levels of free plasmid that could be detected by this method (Fig. 2) . However, a longer exposure of the autoradiogram shown in Fig. 2 As might be expected from the frequencies of G418-resistant colony formation shown in Table 1 , we found that pBamC is maintained as a plasmid in G418-resistant D98/HR1 as well as in D98/Raji (data not shown). As with pBamC, pBamCAJ is maintained under selection as a stable plasmid in both of these EBV genome-positive cell lines (see below).
Stability of pBamC in Nonselected Populations. Three clones of D98/Raji initially containing pBamC plasmid at an average of 4-10 copies per cell were carried with and without G418 selection for a total of 33-35 population doublings. (The copy number of plasmids was determined by using analysis of supernatants of Hirt extracts by the method of Southern as described in the legend to Fig. 2 ; data not shown.) Using a clonal assay, we then measured what fraction of the cells in the nonselected populations were still resistant to G418. Populations that had been grown in the absence of G418 were found to contain 40%, 41%, and 15% G418-resistant cells by this assay ( (Fig. 4 ). These plasmids were tested for their efficiency in stably transfecting D98/Raji and D98/ HR1 cells to G418 resistance. Efficiencies of each plasmid were the same within a factor of two when either D98/Raji or D98/HR1 were used as recipient cells (Fig. 4) . Only two plasmids, pASstII 3 and pASma 24, which contain 2300 bp and 1790 bp, respectively, to the right of the EcoRI site in the center of BamHI C behaved as did pBamC and pBamCAJ. All other plasmids were no more than 1/20th as efficient as One-fifth of the transformed bacteria were plated on ampicillin plates; the remainder were grown overnight in LB medium containing ampicillin, harvested, and their plasmids were isolated by a "miniprep" procedure (34) . The (28) as described in the legend to Fig. 2 . The G418-resistant populations carried (per cell) the following: 5-10 copies of pASstII 3, 1-2 copies of pASma 24, <0.05 copies of pABal 2, and '0.1 copy of pABal 14 as detectable plasmids (data not shown). These results imply that maximally the 1790 bp between EcoRI and Sma I sites on BamHI C are required for stable plasmid replication.
Comparison of plasmids pABal 2 and pABal 14 with pASma 24 gives the minimal length of EBV DNA that contains the information necessary for efficient and stable transfection (Fig. 4) . The Fig. 1 ). pASma 16 (35) , simian virus 40 (36) , and HSV-1 (37, 38) and with cellular genes for ribosomal RNA (39, 40) and dihydrofolate reductase (41) , this interpretation seems likely. Further experiments are necessary to determine whether DNA synthesis initiates within the identified region of BamHI C in EBV plasmids or in recombinant plasmids such as pBamC. For convenience, we will refer to the proposed origin of replication within the identified 1800-bp region as oriP, for origin of plasmid replication. There is no evidence that oriP is involved in lytic replication of linear viral DNA. In preliminary experiments, pBamC sequences were not amplified significantly in D98/HR1 cells induced to replicate the resident viral genomes. EBV may contain origins of replication other than oriP. We may not have detected other origins of replication in EBV, because they are located where our tested clones do not overlap sufficiently, because the tested DNAs contain alterations introduced while cloning them in E. coli, or because they function only during lytic replication.
Three regions of the EBV genome, the BamHI R, the BamHI Y, and the EcoRI D fragments replicate autonomously in yeast (42) . The oriP region, however, does not replicate independently in yeast (ref. 42 ; unpublished results). These observations are consistent with the interpretation that oriP requires an EBV-encoded function in trans to function as an origin of replication. The possible relationship between the sequences found in the EBV genome, which function in yeast (42) , and origins of replication, which function in vertebrate cells, remains to be determined.
The 1800-bp sequence of the oriP region, between EcoRI and Hpa I sites of BamHI C, contains some noteworthy structural features (B. Barrell, A. Bankier, R. Baer, M. Biggin, D. Prescott, P. Farrell, T. Gibson, G. Hatfull, G. Hudson, S. Satchwell, and C. Seguin, personal communication). The leftmost 750 bp of this sequence, required for oriP function (Fig. 4) consist primarily of a family of 30-bp, A+T-rich, tandem direct repeats, repeated 21 times. At the right end of the sequence 1.0 kbp away, three partial copies of the repeat unit lie within the 200 bp shown to be required for oriP function (Fig. 4) , with two of them falling within a 65-bp dyad symmetry. It is interesting to note that ori, of HSV-1 contains 45 bp of dyad symmetry (38) . Both genetic studies (43) and phylogenetic evidence (44, 45) suggest the importance of dyad symmetries in origins of replication of papova viruses. The requirement of oriP for sequences separated by hundreds of base pairs may be analogous to replication in polyomavirus, which apparently involves multiple cis-acting elements (46) .
Only EBV genome-positive cells replicate and maintain pBamC as a plasmid. We believe that EBV expresses functions during latent infection that act in trans to control replication initiation at oriP. We find in preliminary experiments that pBamZRSalF provides functions in trans that permit plasmids carrying oriP to replicate stably in 143 cells. The identification of these cis-and trans-acting functions should facilitate the identification of other functions encoded by EBV, particularly those involved in immortalization of Blymphocytes.
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